These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 20353997

  • 1. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
    Shi Z, Hodges VM, Dunlop EA, Percy MJ, Maxwell AP, El-Tanani M, Lappin TR.
    Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997
    [Abstract] [Full Text] [Related]

  • 2. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
    Aguilar C, Aguilar C, Lopez-Marure R, Jiménez-Sánchez A, Rocha-Zavaleta L.
    Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
    [Abstract] [Full Text] [Related]

  • 3. β Common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase.
    Su KH, Shyue SK, Kou YR, Ching LC, Chiang AN, Yu YB, Chen CY, Pan CC, Lee TS.
    J Cell Physiol; 2011 Dec; 226(12):3330-9. PubMed ID: 21321940
    [Abstract] [Full Text] [Related]

  • 4. Effects of supplemental erythropoietin on its receptor expression and signal transduction pathways in rat model of retinal detachment.
    Xie Z, Chen F, Wu X, Zhuang C, Zhu J, Wang J, Ji H, Wang Y, Hua X.
    Curr Eye Res; 2012 Feb; 37(2):138-44. PubMed ID: 22251399
    [Abstract] [Full Text] [Related]

  • 5. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma.
    Lai SY, Childs EE, Xi S, Coppelli FM, Gooding WE, Wells A, Ferris RL, Grandis JR.
    Oncogene; 2005 Jun 23; 24(27):4442-9. PubMed ID: 15856028
    [Abstract] [Full Text] [Related]

  • 6. Induction of signalling in non-erythroid cells by pharmacological levels of erythropoietin.
    Dunlop EA, Percy MJ, Boland MP, Maxwell AP, Lappin TR.
    Neurodegener Dis; 2006 Jun 23; 3(1-2):94-100. PubMed ID: 16909043
    [Abstract] [Full Text] [Related]

  • 7. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
    Okutani Y, Kitanaka A, Tanaka T, Kamano H, Ohnishi H, Kubota Y, Ishida T, Takahara J.
    Oncogene; 2001 Oct 04; 20(45):6643-50. PubMed ID: 11641791
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis.
    Eckert LB, Repasky GA, Ulkü AS, McFall A, Zhou H, Sartor CI, Der CJ.
    Cancer Res; 2004 Jul 01; 64(13):4585-92. PubMed ID: 15231670
    [Abstract] [Full Text] [Related]

  • 10. Schwann cells express erythropoietin receptor and represent a major target for Epo in peripheral nerve injury.
    Li X, Gonias SL, Campana WM.
    Glia; 2005 Sep 01; 51(4):254-65. PubMed ID: 15812815
    [Abstract] [Full Text] [Related]

  • 11. Erythropoietin induces sustained phosphorylation of STAT5 in primitive but not definitive erythrocytes generated from mouse embryonic stem cells.
    Tsuji-Takayama K, Otani T, Inoue T, Nakamura S, Motoda R, Kibata M, Orita K.
    Exp Hematol; 2006 Oct 01; 34(10):1323-32. PubMed ID: 16982325
    [Abstract] [Full Text] [Related]

  • 12. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2.
    Kilic U, Kilic E, Soliz J, Bassetti CI, Gassmann M, Hermann DM.
    FASEB J; 2005 Feb 01; 19(2):249-51. PubMed ID: 15556972
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury.
    Salahudeen AK, Haider N, Jenkins J, Joshi M, Patel H, Huang H, Yang M, Zhe H.
    Am J Physiol Renal Physiol; 2008 Jun 01; 294(6):F1354-65. PubMed ID: 18385271
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Targeting the erythropoietin receptor on glioma cells reduces tumour growth.
    Pérès EA, Valable S, Guillamo JS, Marteau L, Bernaudin JF, Roussel S, Lechapt-Zalcman E, Bernaudin M, Petit E.
    Exp Cell Res; 2011 Oct 01; 317(16):2321-32. PubMed ID: 21749867
    [Abstract] [Full Text] [Related]

  • 19. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
    Dobbin E, Graham C, Corrigan PM, Thomas KG, Freeburn RW, Wheadon H.
    Exp Hematol; 2009 Jan 01; 37(1):111-121. PubMed ID: 19100521
    [Abstract] [Full Text] [Related]

  • 20. Does erythropoietin have a dark side? Epo signaling and cancer cells.
    Sytkowski AJ.
    Sci STKE; 2007 Jul 17; 2007(395):pe38. PubMed ID: 17636183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.